AstraZeneca signs license agreement with China’s CSPC worth up to $2bn
The agreement includes an upfront payment of $100m with the aim to strengthen the UK firm's cardiovascular portfolio.
October 09, 2024
China's Ministry of Labour and Social Security (MoLSS) has begun accepting applications for a license to provide services to the embryonic enterprise annuities (voluntary corporate pensions) industry.
Registered users get 2 free articles in 30 days.
Subscribers have full unlimited access to FinanceAsia.
Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
Questions?
See here for more information on licences and prices, or contact [email protected].